
|Articles|September 7, 2016
How Many Opioids Have Received ADP Designation on the Basis of Category 1 Studies Alone?
J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.
Advertisement
J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Expands Approval of Ferric Maltol to Adolescents, Addressing a Critical Gap in Iron Deficiency Care
2
Occupational Factors Can Increase Risk of Long COVID
3
FDA Approves First Oral GLP-1 for Weight Management
4
Reading Between the Codes: How Seemingly Unrelated Conditions May Signal Earlier Multiple Myeloma
5




































































































































































































